Airway (AWM) - Total Assets
Based on the latest financial reports, Airway (AWM) holds total assets worth zł12.89 Million PLN (≈ $3.55 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See AWM total equity for net asset value and shareholders' equity analysis.
Airway - Total Assets Trend (2014–2024)
This chart illustrates how Airway's total assets have evolved over time, based on quarterly financial data.
Airway - Asset Composition Analysis
Current Asset Composition (December 2024)
Airway's total assets of zł12.89 Million consist of 86.0% current assets and 14.1% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 55.4% |
| Accounts Receivable | zł1.17 Million | 30.6% |
| Inventory | zł0.00 | 0.0% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł0.00 | 0.0% |
| Goodwill | zł0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Airway's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Airway.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Airway's current assets represent 86.0% of total assets in 2024, an increase from 2.6% in 2014.
- Cash Position: Cash and equivalents constituted 55.4% of total assets in 2024, up from 0.9% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 61.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 30.6% of total assets.
Airway Competitors by Total Assets
Key competitors of Airway based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Airway - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.13 | 0.04 | 1.73 |
| Quick Ratio | 0.12 | 0.04 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł-16.96 Million | zł-18.18 Million | zł9.47 Million |
Airway - Advanced Valuation Insights
This section examines the relationship between Airway's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.99 |
| Latest Market Cap to Assets Ratio | 2.14 |
| Asset Growth Rate (YoY) | -48.2% |
| Total Assets | zł3.82 Million |
| Market Capitalization | $8.15 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Airway's assets at a significant premium (2.14x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Airway's assets decreased by 48.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Airway (2014–2024)
The table below shows the annual total assets of Airway from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | zł3.82 Million ≈ $1.05 Million |
-48.16% |
| 2023-12-31 | zł7.36 Million ≈ $2.03 Million |
+18.48% |
| 2022-12-31 | zł6.21 Million ≈ $1.71 Million |
-86.04% |
| 2021-12-31 | zł44.50 Million ≈ $12.25 Million |
-13.57% |
| 2020-12-31 | zł51.48 Million ≈ $14.17 Million |
+17.63% |
| 2019-12-31 | zł43.77 Million ≈ $12.05 Million |
-4.13% |
| 2018-12-31 | zł45.65 Million ≈ $12.56 Million |
+60.20% |
| 2017-12-31 | zł28.50 Million ≈ $7.84 Million |
-1.65% |
| 2016-12-31 | zł28.98 Million ≈ $7.97 Million |
+26.90% |
| 2015-12-31 | zł22.83 Million ≈ $6.28 Million |
-49.32% |
| 2014-12-31 | zł45.05 Million ≈ $12.40 Million |
-- |
About Airway
Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; Oral Care for intubated hospital … Read more